InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Klee Justin B., Chairman & CEO. Insider active across 1 company, notably Amylyx Pharmaceuticals, Inc.. Aggregated, 3 reports have been logged. History available since 6 January 2022. The latest transaction was filed on 5 May 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations3 total
334,520 shares@ US$0.370.0080% mcap100.0% of flowCommon StockSEC:0000899243-22-017084:0
4,870 shares0Common StockSEC:0000899243-22-001511
4,870 shares0Common StockSEC:0000899243-22-001511:0
3 of 3 declarations
About Klee Justin B.
Justin B. Klee is Co-Chief Executive Officer at Amylyx Pharmaceuticals, Inc. In this role, he leads the company's operations and strategy in the pharmaceutical sector. His expertise in this field allows him to drive innovative initiatives to improve treatments offered to patients.
